EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lessons from IgA Nephropathy Models

Toshiki Kano, Hitoshi Suzuki iD, Yuko Makita, Yoshihito Nihei, Yusuke Fukao iD, Maiko Nakayama iD, Mingfeng Lee, Ryosuke Aoki, Koshi Yamada, Masahiro Muto, Yusuke Suzuki

International Journal of Molecular Sciences · 25.10.2024 · 25 (21) · 11484

DOI: 10.3390/ijms252111484 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.10.2024. Verfasst von Toshiki Kano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo 113-8421, Japan. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Disease Models, Animal, Immunoglobulin A. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IgA nephropathy (IgAN) is the most common type of primary glomerulonephritis worldwide; however, the underlying mechanisms of this disease are not fully understood. This review explores several animal models that provide insights into IgAN pathogenesis, emphasizing the roles of aberrant IgA1 glycosylation and immune complex formation. It discusses spontaneous, immunization, and transgenic models illustrating unique aspects of IgAN development and progression. The animal models, represented by the grouped ddY (gddY) mouse, have provided guidance concerning the multi-hit pathogenesis of IgAN. In this paradigm, genetic and environmental factors, including the dysregulation of the mucosal immune system, lead to increased levels of aberrantly glycosylated IgA, nephritogenic immune complex formation, and subsequent glomerular deposition, followed by mesangial cell activation and injury. Additionally, this review considers the implications of clinical trials targeting molecular pathways influenced by IgAN (e.g., a proliferation-inducing ligand [APRIL]). Collectively, these animal models have expanded the understanding of IgAN pathogenesis while facilitating the development of therapeutic strategies that are currently under clinical investigation. Animal-model-based studies have the potential to facilitate the development of targeted therapies with reduced side effects for IgAN patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, IGADisease Models, AnimalImmunoglobulin AAnimalsHumansMiceGlycosylation

Stichwörter der Autor:innen

APRIL (a proliferation-inducing ligand)IgA nephropathyToll-like receptorsanimal modelsendothelingalactose deficient IgA1immune complex

Substanzen

Immunoglobulin A

Autor:innen und Institutionen

  • Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo 113-8421, Japan.
  • Department of Nephrology, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan.

ORCID-Profile: Hitoshi Suzuki, Yusuke Fukao, Maiko Nakayama

Förderung

  • Japan Society for the Promotion of Science
  • JSPS KAKENHI

Zitieren

APA

Kano, T., Suzuki, H., Makita, Y., Nihei, Y., Fukao, Y., Nakayama, M., Lee, M., Aoki, R., Yamada, K., Muto, M., & Suzuki, Y. (2024). Lessons from IgA Nephropathy Models. International Journal of Molecular Sciences, 25(21), 11484. https://doi.org/10.3390/ijms252111484

Vancouver

Kano T, Suzuki H, Makita Y, Nihei Y, Fukao Y, Nakayama M, et al. Lessons from IgA Nephropathy Models. International Journal of Molecular Sciences. 2024;25(21):11484. doi:10.3390/ijms252111484

BibTeX
@article{Kano2024,
  author = {Kano, Toshiki and Suzuki, Hitoshi and Makita, Yuko and Nihei, Yoshihito and Fukao, Yusuke and Nakayama, Maiko and Lee, Mingfeng and Aoki, Ryosuke and Yamada, Koshi and Muto, Masahiro and Suzuki, Yusuke},
  title = {Lessons from IgA Nephropathy Models},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {21},
  pages = {11484},
  doi = {10.3390/ijms252111484}
}
Kostenlos starten →